Related Experiment Video
Updated: Jan 3, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
Published on: August 1, 2025
Nanoparticles for Immune Cell Reprogramming and Reengineering of Tumor Microenvironment
Ketki Bhise1, Samaresh Sau1, Rami Alzhrani1
1Use-Inspired Biomaterials and Integrated Nano Delivery (U-BiND) Systems Laboratory, Department of Pharmaceutical Sciences, Wayne State University, Detroit, MI, USA.
Abstract:
Nanoparticles in cancer therapy have garnered significant attention in the past few decades. Cancer immunotherapy, which is aptly called "the new-generation cancer therapy," is slowly making remarkable strides in the improvement of patient outcome and longevity. Taken together, nanoparticles in immune therapy have the potential to offer advantages of both nanoparticles and immune therapy on a single platform.
Related Concept Videos
The Tumor Microenvironment
Tumor Immunotherapy

